Matt E Kalaycio MD

Bone Marrow Transplantation

9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273

Dr. Kalaycio is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Kalaycio's full profile Already have an account?

Education & Training

Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1992 - 1994
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1991 - 1992
UPMC Medical Education/MercyResidency, Internal Medicine, 1988 - 1991
West Virginia University School of MedicineClass of 1988

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

OH State Medical License 1990 - 2028
NY State Medical License 2002 - 2022
MI State Medical License 2002 - 2021
PA State Medical License 1990 - 2021
CA State Medical License 2002 - 2020
IL State Medical License 2002 - 2020
FL State Medical License 2016 - 2018
CT State Medical License 2002 - 2006
American Board of Internal Medicine Hematology
Join now to see all

Awards, Honors, & Recognition

CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2011, 2013-2017
CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2011, 2013-2017
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2011, 2013-2017

Clinical Trials

Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
COMPLETED
PHASE2
S0902 Bendamustine and Rituximab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia That Has Not Responded to Previous Treatment
WITHDRAWN
PHASE2
Bendamustine Plus Alemtuzumab for Refractory Chronic Lymphocytic Leukemia (CLL)
TERMINATED
PHASE1

Publications & Presentations

PubMed

1 citations
Neighborhood Socioeconomic Disadvantage and Distance From Treatment Center do not Impact Survival Outcomes of Patients With Non-Hodgkin Lymphoma and Multiple Myeloma T...
Agrima Mian, Rafaella Litvin, Danai Dima, Betty K Hamilton, Allison Winter
Transplantation and Cellular Therapy. 2026-10-01
Longitudinal analysis of tyrosine kinase inhibitor therapy outcomes and BCR-ABL1 transcript decline velocity in chronic myeloid leukemia: A 16-year real-world study.
Moaath K Mustafa Ali, Emily C Zabor, Kamilla Abdurakhmanov, Hadil Zureigat, Ahmed N Mohamed
Cancer. 2026-07-15
2 citations
Infections in steroid-refractory chronic graft versus host disease patients treated with ruxolitinib, ibrutinib, or belumosudil.
Victoria Stepanyants, Hong Li, Danielle Cenin, Jessi Edwards, Claudio Brunstein
Bone Marrow Transplantation. 2025-10-01

Journal Articles

Effect of Bone Marrow CD34+Cells and T-cell Subsets on Clinical Outcomes After Myeloablative Allogeneic Hematopoietic Cell Transplantation
Deepa Jagadeesh, Matt Kalaycio, Brian Bolwell, Betty K Hamilton, Brian Hill, Brad Pohlman, Robert Dean, Navneet S Majhail, Sagar S Patel, Rabi Hanna, Aaron T Gerds, Ro..., Nature
Neutropenic Fever During Peripheral Blood Progenitor Cell Mobilization Is Associated with Decreased CD34+ Cell Collection and Increased Apheresis Collection Days
Mat Kalaycio, Robert Dean, Jack Khouri, Brad Pohlman, Aleksandr Lazaryan, Edward Copelan, Steven Andresen, Ronald Sobecks, Hien Liu, Journal of Clinical Apheresis

Abstracts/Posters

Long-Term Experience with Large Granular Lymphocytic Leukemia Evolving after Solid Organ and Hematopoietic Stem Cell Transplantation
Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Interactions between Donor Activating Killer Immunoglobulin-like Receptors (KIRs) and Somatic Mutations and Their Association with Outcomes after Allogeneic Hematopoie...
Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
Inotuzumab Ozogamicin Post-Transplant for Acute Lymphocytic Leukemia
Matt Kalaycio, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

Association of MHC Class I Chain-Related Gene a (MICA) Polymorphisms with Allogeneic Hematopoietic Cell Transplantation Outcomes in Acute Myeloid Leukemia
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
Survival Outcomes of Patients with Therapy-Related Acute Myeloid Leukemia in the United States
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
TP53 Mutations in Myeloid Neoplasm Patients with and without Significant Personal and Family History of CancerClinically Relevant Abstract
2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Press Mentions

Simmons Cancer Center’s Dr. John Sweetenham to Chair National Comprehensive Cancer Network Board of DirectorsApril 5th, 2022
Why Coronavirus-Related Delays in Cancer Screenings Are Concerning, According to ExpertsMarch 19th, 2021
How the Pandemic Will Affect the Future of Cancer Care: 3 Specialists Weigh InAugust 12th, 2020